Placebo to match mirabegron
Sponsors
Astellas Pharma Europe B.V.
Conditions
Overactive BladderUrgency IncontinenceUrinary Bladder Diseases\Urologic DiseasesUrinary Bladder Overactive
Phase 3
This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
CompletedNCT01972841
Start: 2013-11-05End: 2015-10-22Updated: 2024-10-31
A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder
CompletedNCT02045862
Start: 2014-03-17End: 2016-09-08Updated: 2024-10-31